急性肺损伤与心脏骤停后综合征:叙事性综述
本文为叙事性综述,系统梳理心脏骤停后肺损伤(PALI)的流行病学、病理生理与治疗策略。流行病学研究显示,心脏骤停后存活者中高达50%发生急性肺损伤。病理生理涉及胸外按压相关创伤、肺缺血再灌注损伤、误吸和全身炎症。治疗上,低潮气量通气和优化呼气末正压等肺保护性通气策略已成为PALI管理的基石,治疗性低体温和靶向线粒体功能障碍的新兴疗法显示出前景。作者认为需进一步临床研究以优化PALI管理。
要点
- 心脏骤停后存活者中高达50%发生急性肺损伤,是导致不良结局的重要环节。
- PALI的病理生理包括胸外按压相关创伤、肺缺血再灌注损伤、误吸和全身炎症。
- 低潮气量通气和优化呼气末正压等肺保护性通气策略是PALI管理的基石。
- 胸部X线、计算机断层扫描和肺超声在识别PALI和评估严重程度中起关键作用。
- 治疗性低体温和靶向线粒体功能障碍的新兴疗法在减轻PALI相关并发症和死亡方面显示出前景。
适用人群与场景
- 心脏骤停后综合征(PCAS)患者,尤其是心脏骤停后存活者。
处置流程与药物剂量
- 肺保护性通气策略:低潮气量通气和优化呼气末正压,作为PALI管理的基石方法。
研究设计与关键结果
- 综述汇总现有文献显示,流行病学研究突出PALI在心脏骤停后患者中患病率很高,高达50%的存活者发生急性肺损伤。
- 诊断影像手段包括胸部X线、计算机断层扫描和肺超声,在识别PALI和评估其严重程度中起关键作用。
- 病理生理上,PALI涵盖胸外按压相关创伤、肺缺血再灌注损伤、误吸和全身炎症等一系列因素,共同导致肺功能障碍和不良结局。
- 治疗上,低潮气量通气和优化呼气末正压等肺保护性通气策略已成为PALI管理的基石。
- 治疗性低体温和靶向线粒体功能障碍的新兴疗法在减轻PALI相关并发症和死亡方面显示出前景。
证据类型、等级与局限
- 证据类型:叙事性综述,综合临床前与临床研究文献。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对心脏骤停后患者应警惕PALI,及时诊断并采取靶向干预以改善结局。
- 作者认为,线粒体相关疗法是PALI的新型治疗策略之一,需进一步临床研究以优化PALI管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Post-cardiac arrest syndrome (PCAS) presents a multifaceted challenge in clinical practice, characterized by severe neurological injury and high mortality rates despite advancements in management strategies. One of the important critical aspects of PCAS is post-arrest lung injury (PALI), which significantly contributes to poor outcomes. PALI arises from a complex interplay of pathophysiological mechanisms, including trauma from chest compressions, pulmonary ischemia-reperfusion (IR) injury, aspiration, and systemic inflammation. Despite its clinical significance, the pathophysiology of PALI remains incompletely understood, necessitating further investigation to optimize therapeutic approaches.
METHODS: This review comprehensively examines the existing literature to elucidate the epidemiology, pathophysiology, and therapeutic strategies for PALI. A comprehensive literature search was conducted to identify preclinical and clinical studies investigating PALI. Data from these studies were synthesized to provide a comprehensive overview of PALI and its management.
RESULTS: Epidemiological studies have highlighted the substantial prevalence of PALI in post-cardiac arrest patients, with up to 50% of survivors experiencing acute lung injury. Diagnostic imaging modalities, including chest X-rays, computed tomography, and lung ultrasound, play a crucial role in identifying PALI and assessing its severity. Pathophysiologically, PALI encompasses a spectrum of factors, including chest compression-related trauma, pulmonary IR injury, aspiration, and systemic inflammation, which collectively contribute to lung dysfunction and poor outcomes. Therapeutically, lung-protective ventilation strategies, such as low tidal volume ventilation and optimization of positive end-expiratory pressure, have emerged as cornerstone approaches in the management of PALI. Additionally, therapeutic hypothermia and emerging therapies targeting mitochondrial dysfunction hold promise in mitigating PALI-related morbidity and mortality.
CONCLUSION: PALI represents a significant clinical challenge in post-cardiac arrest care, necessitating prompt diagnosis and targeted interventions to improve outcomes. Mitochondrial-related therapies are among the novel therapeutic strategies for PALI. Further clinical research is warranted to optimize PALI management and enhance post-cardiac arrest care paradigms.
参考来源
- Endo Y, Aoki T, Jafari D, et al. Acute lung injury and post-cardiac arrest syndrome: a narrative review. J Intensive Care. 2024. PMID: 39227997. doi:10.1186/s40560-024-00745-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。